Medicare Enrolled

Dr. Lisa Faia, M.D.

Retina Specialist (Ophthalmology) Physician · Royal Oak, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
3555 W 13 MILE RD, Royal Oak, MI 48073
2482882280
In practice since 2005 (20 years)
NPI: 1407832884 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Faia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Faia? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Faia

Dr. Lisa Faia is a retina specialist physician in Royal Oak, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Faia performed 16,614 Medicare services across 2,496 unique beneficiaries.

Between the years covered by Open Payments, Dr. Faia received a total of $455,920 from 29 pharmaceutical and/or device companies across 533 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Faia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 44% volume in MI $455,920 industry payments

Medicare Practice Summary

Medicare Utilization ↗
16,614
Medicare services
Top 44% in MI for retina specialist (ophthalmology) physician
2,496
Unique beneficiaries
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~831 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
7,260 $29 $45
Injection, ranibizumab, 0.1 mg 3,188 $179 $467
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,333 $96 $220
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,086 $98 $298
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
976 $30 $100
Aflibercept eye injection (Eylea) 856 $673 $1,080
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
733 $28 $125
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
600 $19 $60
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
223 $136 $305
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
160 $110 $280
New patient office visit, complex (60-74 min) 80 $163 $370
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
63 $63 $195
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
25 $11 $45
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
19 $36 $115
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
12 $112 $280
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$455,920
Total received (2018-2024)
Avg $65,131/year across 7 years
Top 6% in MI for retina specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
533
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$417,337 (91.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$30,530 (6.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,053 (1.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$175,699
2023
$98,943
2022
$83,309
2021
$20,432
2020
$11,984
2019
$18,853
2018
$46,701

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alimera Sciences, Inc.
$79,429
Astellas Pharma US Inc
$67,901
Genentech USA, Inc.
$18,474
ABBVIE INC.
$8,228
Bausch & Lomb Americas Inc.
$410
Regeneron Healthcare Solutions, Inc.
$388
Apellis Pharmaceuticals, Inc.
$241
EyePoint Pharmaceuticals US, Inc.
$131
Coherus Biosciences Inc.
$130
Ocular Therapeutix, Inc.
$86
Genentech, Inc.
$73
ANI Pharmaceuticals, Inc.
$60
Sandoz Inc.
$58
Astellas US LLC
$44
Mallinckrodt Hospital Products Inc.
$30
Biogen, Inc.
$18
Top 3 companies account for 94.4% of 2024 payments
All-time payments by company (2018-2024) ›
Alimera Sciences, Inc.
$103,343
Genentech USA, Inc.
$92,661
Astellas Pharma US Inc
$90,498
EyePoint Pharmaceuticals US, Inc.
$40,344
Allergan Inc.
$38,895
Allergan, Inc.
$27,841
ABBVIE INC.
$21,356
AbbVie, Inc.
$18,235
Janssen Global Services, LLC
$11,395
Bausch & Lomb, a division of Bausch Health US, LLC
$6,225
Bausch & Lomb Americas Inc.
$1,218
Regeneron Healthcare Solutions, Inc.
$1,092
Coherus Biosciences Inc.
$448
Mallinckrodt Enterprises LLC
$432
Apellis Pharmaceuticals, Inc.
$336
Oculus Surgical Inc.
$259
Mallinckrodt Hospital Products Inc.
$209
ANI Pharmaceuticals, Inc.
$153
Mallinckrodt LLC
$132
Genentech, Inc.
$128
Regeneron Pharmaceuticals, Inc.
$125
Alcon Vision LLC
$119
Novartis Pharmaceuticals Corporation
$116
Ocular Therapeutix, Inc.
$86
ThromboGenics, Inc.
$77
Biogen, Inc.
$72
Sandoz Inc.
$58
Astellas US LLC
$44
AbbVie Inc.
$23
Top 3 companies account for 62.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALREX · BEOVU · BYOOVIZ · Cimerli · Clareon · Constellation · DEXTENZA · DEXYCU · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · EYP-1901 · HUMIRA · Humira · ILUVIEN · Izervay · Jetrea · Lucentis · MIEBO · OZURDEX · PURIFIED CORTROPHIN GEL · RETISERT · SUSVIMO · Stellaris · Susvimo · Syfovre · VABYSMO · VISUDYNE · Vabysmo · XIPERE · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in retina specialist (ophthalmology) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for retina specialist (ophthalmology) physician in MI.

Looking for a retina specialist physician in Royal Oak?
Compare retina specialist physicians in the Royal Oak area by procedure volume, costs, and industry payment transparency.
Browse retina specialist physicians nearby

Geographic Context

Retina specialist physicians within 10 mi
10
Per 100K population
0.8
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL ROYAL OAK
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Faia is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 6% of MI peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Faia experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Faia performed 7,260 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Faia receive payments from pharmaceutical companies?
Yes. Dr. Faia received a total of $455,920 from 29 companies across 533 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Faia's costs compare to other retina specialist physicians in Royal Oak?
Dr. Faia's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Faia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →